These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evaluation of L-dopa therapy in Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ N Y State J Med; 1970 Sep; 70(18):2309-18. PubMed ID: 5272106 [No Abstract] [Full Text] [Related]
27. [Therapy of Parkinson's syndrome with L-dopa only and in combination with a decarboxylase inhibitor. A comparison]. Feise G; Paal G Nervenarzt; 1974 Mar; 45(3):126-32. PubMed ID: 4832035 [No Abstract] [Full Text] [Related]
28. [Personal experience in the treatment of Parkinson's disease with L-Dopa]. Figuerido JA; De la Herrán J Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794 [No Abstract] [Full Text] [Related]
29. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases]. Herskovits E; Matera R; Gacitua EF Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629 [No Abstract] [Full Text] [Related]
30. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease]. van der Drift JH Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073 [No Abstract] [Full Text] [Related]
32. [Silent period in patients with Parkinson's disease treated with L-Dopa]. Palao Sánchez A Arch Neurobiol (Madr); 1973; 36(1):47-56. PubMed ID: 4706780 [No Abstract] [Full Text] [Related]
33. L-dopa therapy in Parkinson's disease. Murray TJ N S Med Bull; 1972 Jun; 51(3):67-70. PubMed ID: 4504954 [No Abstract] [Full Text] [Related]
34. The effects of L-dopa therapy in Parkinson's disease. Thompson RA; White JC; Echols CL Ariz Med; 1970 Jul; 27(7):5-10. PubMed ID: 5432717 [No Abstract] [Full Text] [Related]
35. Management of Parkinson's disease with L-dopa therapy. Tyler E Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360 [No Abstract] [Full Text] [Related]
36. [Our experience with the treatment of Parkinson's disease with L-dopa]. Buscaino GA; Campanella G Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941 [No Abstract] [Full Text] [Related]
37. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease. Van Woert MH Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103 [No Abstract] [Full Text] [Related]
38. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L; Martin JD; Gutrecht JA W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
39. [L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease]. Lakke JP; Nienhuis RJ; Meyer R; Zwols F; Schut T Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2180-4. PubMed ID: 4639072 [No Abstract] [Full Text] [Related]
40. [Treatment of Parkinson's syndrome with L-dopa]. Kaeser HE; Ferel D; Wurmser P Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]